News

BioNTech SE is currently sponsoring a Phase II clinical study titled A Phase II, Multisite, Open-label, Single Arm Trial of BNT327 in Combination With Docetaxel in Second-line Stage IV Non-small Cell ...
New data from the Kentucky Cabinet for Health and Family Services shows cases of the virus have jumped significantly in the ...
Since COVID, there've been growing initiatives in Africa to start producing vaccines and medicines locally, thus gaining greater independence from global supply chains. But are these schemes ...
The NHS has announced that it will fast-track patients with advanced head and neck cancers in England into a clinical trial of an investigational cancer vaccine. Over 100 patients will be matched to ...
Health Canada announced it has approved a new vaccine made by Pfizer Canada and BioNTech for the fall of 2025. According to ...
The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...
"This isn't a political statement," Dr. Lee Vogel said about vaccine safety. "This is just trying to provide some factual ...
RFK Jr is cutting $500m in funding for mRNA vaccines for diseases like flu and COVID-19, but critics say his reasons for doing so are spurious.
Ascendis Pharma's TransCon platform shows promise, but challenges with rollout, competition, and execution risks lead to a Hold rating.
For the first time in 30 years, the American Academy of Pediatrics is substantially diverging from U.S. government vaccine recommendations. The group’s new COVID-19 recommendations were released ...
The American Academy of Pediatrics updated its recommendations for immunizations Tuesday, including calling for COVID shots for healthy kids, diverging ...